Literature DB >> 7410447

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents.

M A Phelan, R E Mayner, D J Bucher, F A Ennis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410447     DOI: 10.1016/s0092-1157(80)80039-4

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


× No keyword cloud information.
  20 in total

1.  Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.

Authors:  T G Evans; T Fitzgerald; D C Gibbons; M C Keefer; H Soucier
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.

Authors:  D B Burlington; M L Clements; G Meiklejohn; M Phelan; B R Murphy
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

3.  Mitogenicity of influenza hemagglutinin glycoproteins and influenza viruses bearing H2-hemagglutinin.

Authors:  R B Armstrong; G M Butchko; S C Kiley; M A Phelan; F A Ennis
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus.

Authors:  Tadaki Suzuki; Akira Kawaguchi; Akira Ainai; Shin-ichi Tamura; Ryo Ito; Pretty Multihartina; Vivi Setiawaty; Krisna Nur Andriana Pangesti; Takato Odagiri; Masato Tashiro; Hideki Hasegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

5.  Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.

Authors:  G J Gorse; R B Belshe
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

6.  Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses.

Authors:  B R Murphy; M A Phelan; D L Nelson; R Yarchoan; E L Tierney; D W Alling; R M Chanock
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

7.  Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Determination of antibody response to influenza virus surface glycoproteins by kinetic enzyme-linked immunosorbent assay.

Authors:  M H Snyder; S Banks; B R Murphy
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

9.  Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children.

Authors:  D B Burlington; P F Wright; K L van Wyke; M A Phelan; R E Mayner; B R Murphy
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

Authors:  K S Chen; D B Burlington; G V Quinnan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.